December 27, 2014 11:46 PM ET


Company Overview of Tragara Pharmaceuticals, Inc.

Company Overview

Tragara Pharmaceuticals, Inc., a pharmaceutical company, engages in the clinical and commercial development of drugs for the treatment of cancers and inflammation. Its Capoxigem is used for lung and pancreatic cancers. The company was incorporated in 2005 and is based in San Diego, California.

10955 Vista Sorrento Parkway

Suite 120

San Diego, CA 92130

United States

Founded in 2005





Key Executives for Tragara Pharmaceuticals, Inc.

Chief Executive Officer
Co-Founder and Chief Development Officer
Senior Director of Finance
Chief Business Officer
Head of Oncology Biology
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
OMJ Pharmaceuticals, Inc. United States
VersaPharm Incorporated United States
Bayer Capital Corporation United States
Equon Pharmaceuticals, Inc. United States
Tibotec Therapeutics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tragara Pharmaceuticals, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at